169 related articles for article (PubMed ID: 31619667)
1. NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma.
Frisira E; Rashid F; Varma SN; Badodi S; Benjamin-Ombo VA; Michod D; Niklison-Chirou MV
Cell Death Dis; 2019 Oct; 10(11):785. PubMed ID: 31619667
[TBL] [Abstract][Full Text] [Related]
2. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
[TBL] [Abstract][Full Text] [Related]
3. Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma.
Chauhan D; Singh AV; Ciccarelli B; Richardson PG; Palladino MA; Anderson KC
Blood; 2010 Jan; 115(4):834-45. PubMed ID: 19965674
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model.
Singh AV; Palladino MA; Lloyd GK; Potts BC; Chauhan D; Anderson KC
Br J Haematol; 2010 May; 149(4):550-9. PubMed ID: 20331453
[TBL] [Abstract][Full Text] [Related]
5. The Proteasome Inhibitor CEP-18770 Induces Cell Death in Medulloblastoma.
Nath Varma S; Ye S; Ferlin S; Comer C; Cotton K; Niklison-Chirou MV
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794334
[TBL] [Abstract][Full Text] [Related]
6. NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells.
Miller CP; Ban K; Dujka ME; McConkey DJ; Munsell M; Palladino M; Chandra J
Blood; 2007 Jul; 110(1):267-77. PubMed ID: 17356134
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity.
Yu CC; Chiou GY; Lee YY; Chang YL; Huang PI; Cheng YW; Tai LK; Ku HH; Chiou SH; Wong TT
Childs Nerv Syst; 2010 Jul; 26(7):897-904. PubMed ID: 20179950
[TBL] [Abstract][Full Text] [Related]
8. A novel proteasome inhibitor NPI-0052 as an anticancer therapy.
Chauhan D; Hideshima T; Anderson KC
Br J Cancer; 2006 Oct; 95(8):961-5. PubMed ID: 17047643
[TBL] [Abstract][Full Text] [Related]
9. Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway.
Crowther AJ; Ocasio JK; Fang F; Meidinger J; Wu J; Deal AM; Chang SX; Yuan H; Schmid R; Davis I; Gershon TR
Cancer Res; 2016 Jun; 76(11):3211-23. PubMed ID: 27197166
[TBL] [Abstract][Full Text] [Related]
10. The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia.
Ruiz S; Krupnik Y; Keating M; Chandra J; Palladino M; McConkey D
Mol Cancer Ther; 2006 Jul; 5(7):1836-43. PubMed ID: 16891470
[TBL] [Abstract][Full Text] [Related]
11. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.
Chauhan D; Catley L; Li G; Podar K; Hideshima T; Velankar M; Mitsiades C; Mitsiades N; Yasui H; Letai A; Ovaa H; Berkers C; Nicholson B; Chao TH; Neuteboom ST; Richardson P; Palladino MA; Anderson KC
Cancer Cell; 2005 Nov; 8(5):407-19. PubMed ID: 16286248
[TBL] [Abstract][Full Text] [Related]
12. Exploring the role and clinical implications of proteasome inhibition in medulloblastoma.
Hoerig CM; Plant-Fox AS; Pulley MD; Di K; Bota DA
Pediatr Blood Cancer; 2021 Oct; 68(10):e29168. PubMed ID: 34114315
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
Chen SM; Li YY; Tu CH; Salazar N; Tseng YY; Huang SF; Hsieh LL; Lui TN
PLoS One; 2016; 11(8):e0161299. PubMed ID: 27537345
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.
Markowitz D; Powell C; Tran NL; Berens ME; Ryken TC; Vanan M; Rosen L; He M; Sun S; Symons M; Al-Abed Y; Ruggieri R
Mol Cancer Ther; 2016 Aug; 15(8):1799-808. PubMed ID: 27207779
[TBL] [Abstract][Full Text] [Related]
15. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
Patties I; Kortmann RD; Menzel F; Glasow A
J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342
[TBL] [Abstract][Full Text] [Related]
16. Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
Levin N; Spencer A; Harrison SJ; Chauhan D; Burrows FJ; Anderson KC; Reich SD; Richardson PG; Trikha M
Br J Haematol; 2016 Sep; 174(5):711-20. PubMed ID: 27161872
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life in Paediatric Survivors of Medulloblastoma.
Tariq R; Saeed Baqai MW; Shamim MS
J Pak Med Assoc; 2022 Nov; 72(11):2339-2340. PubMed ID: 37013321
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
Baritaki S; Chapman A; Yeung K; Spandidos DA; Palladino M; Bonavida B
Oncogene; 2009 Oct; 28(40):3573-85. PubMed ID: 19633685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
